Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Predicting Oxygen Desaturation in Chronic Obstructive Pulmonary Disease (COPD) Patients

This study has been completed.
Sponsor:
Information provided by:
Villa Pineta Hospital
ClinicalTrials.gov Identifier:
NCT01303913
First received: February 24, 2011
Last updated: February 25, 2011
Last verified: February 2011
  Purpose

Oxygen desaturation (SO2 < 88-90%) during walking is a common clinical feature of Chronic Obstructive Pulmonary Disease (COPD) patients. By a predicted analysis our study is aimed to evaluate anthropometric and functional characteristics of COPD patients correlated with oxygen desaturation during Six-minute walking test (6MWT).


Condition
COPD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Composite Analysis on Factors That Predict Oxygen Desaturation During Walking in COPD

Resource links provided by NLM:


Further study details as provided by Villa Pineta Hospital:

Primary Outcome Measures:
  • Oxygen saturation nadir (SO2 nadir) [ Time Frame: Measured at the end of 6MWT ] [ Designated as safety issue: No ]
    Measured by change in percentage (%)


Enrollment: 400
Study Start Date: June 2010
Study Completion Date: February 2011
Groups/Cohorts
Walking desaturation group
COPD patients that at the end of 6MWT have SO2 nadir <88-90%
Walking No-desaturation group
COPD patients that at the end of 6MWT have SO2 nadir >88-90%

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

COPD patients

Criteria

Inclusion Criteria:

  • COPD patients
  • Ability to perform 6MWT
  • Normal oxygen saturation at rest and at the begin of 6MWT

Exclusion Criteria:

  • No-COPD patients
  • Chronic Respiratory Failure patients in Long-term oxygen therapy (LTOT)
  • Any co-morbidities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01303913

Locations
Italy
Villa Pineta Hospital
Pavullo nel Frignano, Modena, Italy, 41026
Sponsors and Collaborators
Villa Pineta Hospital
Investigators
Principal Investigator: Ernesto Crisafulli, MD, PhD Villa Pineta Hospital
  More Information

No publications provided by Villa Pineta Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Villa Pineta Hospital
ClinicalTrials.gov Identifier: NCT01303913     History of Changes
Other Study ID Numbers: VP03-2010
Study First Received: February 24, 2011
Last Updated: February 25, 2011
Health Authority: Italy: Villa Pineta Fundation Review Board

Keywords provided by Villa Pineta Hospital:
COPD
Oxygen desaturation
Walking test

Additional relevant MeSH terms:
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 25, 2014